Compare · CVET vs HKPD
CVET vs HKPD
Side-by-side comparison of Covetrus Inc. (CVET) and Cellyan Biotechnology Co. Ltd (HKPD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CVET and HKPD operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- CVET carries a market cap of $2.42B.
- HKPD has hit the wire 1 time in the past 4 weeks while CVET has been quiet.
- CVET has more recent analyst coverage (8 ratings vs 0 for HKPD).
- Company
- Covetrus Inc.
- Cellyan Biotechnology Co. Ltd
- Price
- $21.00+0.24%
- $0.65-12.02%
- Market cap
- $2.42B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 0
- 1
- Recent ratings
- 8
- 0
Covetrus Inc.
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.
Latest CVET
- Semrush Strengthens Customer Focus with Appointment of Veronique Montreuil as Chief Customer and Data Officer
- Key Cannabis Exec Changes You Need To Know About: Leafly's New CCO, Glass House's New Appointment & More
- SEC Form 15-12G filed by Covetrus Inc.
- Westlake Set to Join S&P MidCap 400; MillerKnoll to Join S&P SmallCap 600
- Westlake Set To Join S&P MidCap 400, Replacing MillerKnoll; MillerKnoll To Replace Coventrus In S&P SmallCap 600
- SEC Form SC 13D/A filed by Covetrus Inc. (Amendment)
- SEC Form 4: Cd&R Investment Associates Ix, Ltd. disposed of 33,670,541 shares
- SEC Form S-8 POS filed by Covetrus Inc.
- SEC Form SC 13E3/A filed by Covetrus Inc. (Amendment)
- Covetrus Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
Latest HKPD
- SEC Form EFFECT filed by Cellyan Biotechnology Co. Ltd
- SEC Form F-1 filed by Cellyan Biotechnology Co. Ltd
- SEC Form 6-K filed by Cellyan Biotechnology Co. Ltd
- SEC Form 6-K filed by Cellyan Biotechnology Co. Ltd
- SEC Form 6-K filed by Cellyan Biotechnology Co. Ltd
- Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
- SEC Form 6-K filed by Hong Kong Pharma Digital Technology Holdings Limited
- SEC Form 6-K filed by Hong Kong Pharma Digital Technology Holdings Limited
- Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders
- SEC Form 6-K filed by Hong Kong Pharma Digital Technology Holdings Limited